A novel perspective for an orphan problem: old and new drugs for the medical management of malignant ascites.
about
Evaluation and treatment of malignant ascites secondary to gastric cancerCell-cell and cell-matrix dynamics in intraperitoneal cancer metastasisAcellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells.Management of non-ovarian cancer malignant ascites through indwelling catheter drainage.Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites.Oxidative dna damage of lymphocytes in peripheral blood and ascites in cancer patients.Emerging treatment options for management of malignant ascites in patients with ovarian cancer.Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer.The contribution of catumaxomab in the treatment of malignant ascites in patients with ovarian cancer: a review of the literature.Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study.Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study.A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer.
P2860
Q26780301-4B21FE09-D4F9-4D0F-B342-FCFE4B1D2FAAQ26851836-029DA7BC-C6FB-4D29-B1E7-A3A7BA86F7D1Q34781244-F1764C71-24EE-4B49-8474-7913CC1D77CDQ35996680-7A463251-D5F1-458C-B065-974E351DD0BEQ36139548-55BAC31F-562D-4B79-AFEA-DD9CD087E3ABQ36145315-5C00C77D-E412-43C0-BE92-8CB56A5284FFQ36173084-9C4876DD-423C-4712-96D7-E906511039ACQ37225693-279C1DA8-C540-4017-8576-1A2A7B70596DQ38104263-E0CD1398-C11A-42E2-A114-70A75ACD8DD3Q40202331-5B9B4602-56F2-4361-A95F-5BCB75AAED9FQ43728324-150FB4AA-3550-4CBE-B0A1-064985BDAD66Q48082239-D93C3420-D245-4B02-95A0-71499E12B6FE
P2860
A novel perspective for an orphan problem: old and new drugs for the medical management of malignant ascites.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel perspective for an orp ...... nagement of malignant ascites.
@en
A novel perspective for an orp ...... nagement of malignant ascites.
@nl
type
label
A novel perspective for an orp ...... nagement of malignant ascites.
@en
A novel perspective for an orp ...... nagement of malignant ascites.
@nl
prefLabel
A novel perspective for an orp ...... nagement of malignant ascites.
@en
A novel perspective for an orp ...... nagement of malignant ascites.
@nl
P2093
P1476
A novel perspective for an orp ...... nagement of malignant ascites.
@en
P2093
P304
P356
10.1016/J.CRITREVONC.2010.07.016
P577
2010-08-13T00:00:00Z